CD8A and Miyoshi myopathy: In order to use immunological biomarkers or an immunological formula to detect asbestos exposure and/or the occurrence of MM, a standardized method must be employed regarding how venous-drawn peripheral blood is divided, for example, into plasma and lymphocytes (or into CD4+, CD8+ cells, and NK cells).